Advertisement

Cytochrome P450c17: Regulation of Gene Expression and Enzyme Function at the Bifurcation in Steroid Hormone Synthesis

  • W. N. Kühn-Velten
Chapter
  • 380 Downloads
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 105)

Abstract

Cytochrome P450c17 is a member of the cytochrome P450 gene superfamily (Nebert et al. 1991) that is of special interest because of its functional significance, catalytic properties, and hormonal regulation. Located in the membranes of the smooth endoplasmic reticulum in steroidogenic cells, cytochrome P450c17 is the terminal substrate-binding and oxygen-activating heme protein in a monooxygenase system which is able to catalyze a two-step reaction sequence, i.e., a first oxygen- and NADPH-dependent hydroxylation of a C21 steroid (pregnenolone or progesterone) in the C17α position (yielding 17α-hydroxypregnenolone or 17α-hydroxyprogesterone), which may be (but is not necessarily) followed by a second NADPH- dependent oxygen activation and insertion resulting in a C-C bond cleavage yielding C19 steroids (dehydroepiandrosterone or androstenedione). Thus, depending on the further enzyme equipment of an endocrine active cell, the reaction intermediate can either be processed towards glucocorticoids (Cortisol and 11-deoxyCortisol) or to androgens (mainly testosterone) and estrogens (mainly estradiol). Cytochrome P450c17 therefore occupies an important position at a metabolic branchpoint (Hall 1986; Simpson and Waterman 1988). Since the discovery of cytochrome P450c17 in testicular microsomes (Menard and Purvis 1973), major methodological breakthroughs in membrane protein purification (Nakajin and Hall 1981), protein and DNA sequence analysis, heterologous gene expression, and computer-aided modeling have provided increasing information about this enzyme.

Keywords

Leydig Cell Lyase Activity Steroidogenic Enzyme Microsomal Cytochrome Testis Microsome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angelastro MR, Laughlin ME, Schatzman GL, Bey P, Blohm TR (1989) 17ß-(Cyclopropylamino)-androst-5-en-3ß-ol, a selective mechanism-based inhibitor of cytochrome P45017α (steroid 17α-hydroxylase/C17-20 lyase). Biochem Biophys Res Commun 162: 1571–1577Google Scholar
  2. Barnes HJ, Arlotto MP, Waterman MR (1991) Expression and enzymatic activity of recombinant cytochrome P450 17α-hydroxylase in Escherichia coli. Proc Natl Acad Sei USA 88: 5597–5601CrossRefGoogle Scholar
  3. Bhasker CR, Adler BS, Dee A, John ME, Kagimoto M, Zuber MX, Ahlgren R, Wang X, Simpson ER, Waterman MR (1989) Structural characterization of the bovine CYP17 (17α-hydroxylase) gene. Arch Biochem Biophys 271: 479–487PubMedCrossRefGoogle Scholar
  4. Clark BJ, Waterman MR (1991) The hydrophobic amino-terminal sequence of bovine 17α-hydroxylase is required for the expression of a functional hemoprotein in COS1 cells. J Biol Chem 266: 5898–5904PubMedGoogle Scholar
  5. Couch RM, Muller J, Winter JSD (1986) Regulation of the activities of 17-hydroxylase and 17,20-desmolase in the human adrenal cortex: kinetic analysis and inhibition by endogenous steroids. J Clin Endocrinol Metab 63: 613–618PubMedCrossRefGoogle Scholar
  6. Dufau ML (1988) Endocrine regulation and communicating functions of the Ley dig cell. Annu Rev Physiol 50: 483–508PubMedCrossRefGoogle Scholar
  7. Eckstein B, Greenbaum O, Cohen S (1985) Kinetic studies on ovarian C-17,20-lyase activity: effect of luteinizing hormone surge. Endocrinology 117: 2376–2382PubMedCrossRefGoogle Scholar
  8. Edwards RJ, Murray BP, Singleton AM, Boobis AR (1991) Orientation of cytochromes P450 in the endoplasmic reticulum. Biochemistry 30: 71–76PubMedCrossRefGoogle Scholar
  9. Hales DB, Sha L, Payne AH (1987) Testosterone inhibits cAMP-induced de novo synthesis of Leydig cell cytochrome P-45017α by an androgen receptor-mediated mechanism. J Biol Chem 262: 11200–11206PubMedGoogle Scholar
  10. Hall PF (1986) Cytochromes P-450 and the regulation of steroid synthesis. Steroids 48: 131–196PubMedCrossRefGoogle Scholar
  11. Hedin L, Rodgers RJ, Simpson ER, Richards JS (1987) Changes in content of cytochrome P45017α, cytochrome P450scc, and 3-hydroxy-3-methylglutaryl CoA reductase in developing rat ovarian follicles and corpora lutea: correlation with theca cell steroidogenesis. Biol Reprod 37: 211–223PubMedCrossRefGoogle Scholar
  12. Higashi Y, Omura M, Suzuki K, Inano H, Oshima H (1987) Ketoconazole as a possible universal inhibitor of cytochrome P-450 dependent enzymes: its mode of inhibition. Endocrinol Jpn 34: 105–115PubMedCrossRefGoogle Scholar
  13. Hornsby PJ, Crivello JF (1983) The role of lipid peroxidation and biological antioxidants in the function of the adrenal cortex. Mol Cell Endocrinol 30: 123–147PubMedCrossRefGoogle Scholar
  14. Johnson DC (1988) Loss of ovarian 17α-hydroxylase/C17,20-lyase activity induced by human chorionic gonadotropin is correlated with in vivo substrate availability. J Steroid Biochem 29: 545–551PubMedCrossRefGoogle Scholar
  15. Johnson DC, Sen M (1990) The cytochrome P45017α (17α-hydroxylase/C17,20-lyase) activity of the junctional zone of the rat placenta. J Endocrinol 125: 217–224PubMedCrossRefGoogle Scholar
  16. Kominami S, Inoue S, Higuchi A, Takemori S (1989) Steroidogenesis in liposomal system containing adrenal microsomal cytochrome P-450 electron transfer components. Biochim Biophys Acta 985: 293–299PubMedCrossRefGoogle Scholar
  17. Kühn-Velten WN (1991) Thermodynamics and modulation of progesterone microcompartmentation and hydrophobic interaction with cytochrome P450XVII based on quantification of local ligand concentrations in a complex multicomponent system. Eur J Biochem 197: 381–390PubMedCrossRefGoogle Scholar
  18. Kühn-Velten N, Staib W (1984) Effect of human chorionic gonadotropin and estradiol in vivo on estradiol binder and cytochrome P-450 concentrations in rat testis. J Steroid Biochem 20: 555–561PubMedCrossRefGoogle Scholar
  19. Kühn-Velten N, Bunse T, Schürer N, Staib W (1984a) Direct effects of androgens on progesterone binding and metabolism in rat testis microsomes. Hoppe-Seyler’s Z Physiol Chem 365: 773–779PubMedCrossRefGoogle Scholar
  20. Kühn-Velten N, Codjambopoulo P, Waldenburger D, Herberg L, Kley HK, Staib W (1984b) Testicular endocrine function in vitro in animals with chemically induced or genetically determined diabetes mellitus. In: Shafrir E, Renold AE (eds) Lessons from animal diabetes. Libbey, London, pp 787–791Google Scholar
  21. Kühn-Velten N, Bos D, Staib W (1986) Differential down-regulation and induction responses of testicular steroidogenic cytochromes P450(cscc) and P450(C17α) to human choriogonadotropin. Biosci Rep 6: 451–457PubMedCrossRefGoogle Scholar
  22. Kühn-Velten N, Bos D, Schermer R, Staib W (1987) Age-dependence of the rat Ley dig cell and Sertoli cell function. Development of the peripheral testosterone level and its relation to mitochondrial and microsomal cytochromes P-450 and to androgen-binding protein. Acta Endocrinol 115: 275–281PubMedGoogle Scholar
  23. Kühn-Velten N, Lessmann M, Förster MEC, Staib W (1988) Specific accumulation of 17α-hydroxyprogesterone in microsomal membranes during the process of cytochrome P-450(C-17)-catalysed androgen biosynthesis. A dynamic study of intermediate formation and turnover. Biochem J 256: 53–59PubMedGoogle Scholar
  24. Kühn-Velten N, Meyer I, Staib W (1989) Specificity of steroid binding to testicular cytochrome P-450. Relation of steroid structure to type-I spectral responses after correction for hydrophobic association with the membrane. J Steroid Biochem 33: 33–39PubMedCrossRefGoogle Scholar
  25. Kühn-Velten WN, Herzog AG, Müller MR (1990) Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis. Eur J Pharmacol 181: 151–155PubMedCrossRefGoogle Scholar
  26. Kühn-Velten WN, Bunse T, Förster MEC (1991) Enzyme kinetic and inhibition analyses of cytochrome P450XVII, a protein with a bifunctional catalytic site. Quantification of effective substrate concentrations at the active site and their significance for intrinsic control of the hydroxylase/lyase reaction sequence. J Biol Chem 266: 6291–6301PubMedGoogle Scholar
  27. Laughton CA, Neidle S, Zvelebil MJJM, Sternberg MJE (1990) A molecular model for the enzyme cytochrome P45017α, a major target for the chemotherapy of prostatic cancer. Biochem Biophys Res Commun 171: 1160–1167PubMedCrossRefGoogle Scholar
  28. Lorence MC, Trant JM, Clark BJ, Khyatt B, Mason JI, Estabrook RW, Waterman MR (1990) Construction and expression of human/bovine P45017α chimeric proteins: evidence for distinct tertiary structures in the same P450 from two different species. Biochemistry 29: 9819–9824PubMedCrossRefGoogle Scholar
  29. Lund J, Ahlgren R, Wu D, Kagimoto M, Simpson ER, Waterman MR (1990) Transcriptional regulation of the bovine CYP17 (P-45017α) gene. Identification of two cAMP regulatory regions lacking the consensus cAMP-responsive element (CRE). J Biol Chem 265: 3304–3312PubMedGoogle Scholar
  30. Matteson KJ, Picado-Leonard J, Chung BC, Mohandas TK, Miller WL (1986) Assignment of the gene for adrenal P450c17 (steroid 17α-hydroxylase/17,20 lyase) to human chromosome 10. J Clin Endocrinol Metab 63: 789–791PubMedCrossRefGoogle Scholar
  31. Menard RH, Purvis JL (1973) Studies of cytochrome P-450 in testis microsomes. Arch Biochem Biophys 154: 8–18PubMedCrossRefGoogle Scholar
  32. Nakajin S, Hall PF (1981) Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of a C21 steroid side-chain cleavage system (17α-hydroxylase-C17,20 lyase). J Biol Chem 256: 3871–3876PubMedGoogle Scholar
  33. Namiki M, Kitamura M, Buczko E, Dufau ML (1988) Rat testis P-45017α cDNA: the deduced amino acid sequence, expression and secondary structural configuration. Biochem Biophys Res Commun 157: 705–712PubMedCrossRefGoogle Scholar
  34. Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyereisen R, Fujii-Kuriyama Y, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Loper JC, Sato R, Waterman MR, Waxman DJ (1991) The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 10: 1–14PubMedCrossRefGoogle Scholar
  35. Nelson DR, Strobel HW (1989) Secondary structure prediction of 52 membrane-bound cytochromes P450 shows a strong structural similarity to P450cam. Biochemistry 28: 656–660PubMedCrossRefGoogle Scholar
  36. Pakarinen P, Vihko KK, Voutilainen R, Huhtaniemi I (1990) Differential response of luteinizing hormone receptor and steroidogenic enzyme gene expression to human chorionic gonadotropin stimulation in the neonatal and adult rat testis. Endocrinology 127: 2469–2474PubMedCrossRefGoogle Scholar
  37. Perrin A, Defaye G, Guidicelli C, Chambaz EM (1989) Purification and properties of bovine testicular and adrenal cytochrome P-450 (17α-hydroxylase 17–20 lyase). In: Schuster I (ed) Cytochrome P-450: biochemistry and biophysics. Taylor and Francis, London, pp 117–120Google Scholar
  38. Rainey WE, Naville D, Saez JM, Carr BR, Byrd W, Magness RR, Mason JI (1990) Transforming growth factor-P inhibits steroid 17α-hydroxylase cytochrome P-450 expression in ovine adrenocortical cells. Endocrinology 127: 1910–1915PubMedCrossRefGoogle Scholar
  39. Sasano H, Mason JI, Sasano N (1989) Immunohistochemical analysis of cytochrome P-450 17α-hydroxylase in pig adrenal cortex, testis and ovary. Mol Cell Endocrinol 62: 197–202PubMedCrossRefGoogle Scholar
  40. Simpson ER, Waterman MR (1988) Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 50: 427–440PubMedCrossRefGoogle Scholar
  41. Smals AG, Pieters GF, Kloppenborg PW (1981) Indirect evidence of chronic Leydig cell desensitization in Klinefelter’s syndrome. Acta Endocrinol 96: 552–556PubMedGoogle Scholar
  42. Suzuki K, Tamaoki BI (1983) Acute decrease by human chorionic gonadotropin of the activity of preovulatory ovarian 17α-hydroxylase and C-17-C-20 lyase is due to decrease of microsomal cytochrome P-450 through de novo synthesis of ribonucleic acid and protein. Endocrinology 113: 1985–1991PubMedCrossRefGoogle Scholar
  43. Takayanagi R, Kato KI, Ibayashi H (1986) Relative inactivation of steroidogenic enzyme activities of in vitro vitamin E-depleted human adrenal microsomes by lipid peroxidation. Endocrinology 119: 464–469PubMedCrossRefGoogle Scholar
  44. Van Wauwe JP, Janssen PAH (1989) Is there a case for P-450 inhibitors in cancer treatment? J Med Chem 32: 2231–2239PubMedCrossRefGoogle Scholar
  45. Vergeres G, Winterhalter KH, Richter C (1991) Localization of the N-terminal methionine of rat liver cytochrome P-450 in the lumen of the endoplasmic reticulum. Biochim Biophys Acta 1063: 235–241PubMedCrossRefGoogle Scholar
  46. Yanase T, Kagimoto M, Suzuki S, Hashiba K, Simpson ER, Waterman MR (1989) Deletion of a phenylalanine in the N-terminal region of human cytochrome P-45017α results in partial combined 17α-hydroxylase/17,20-lyase deficiency. J Biol Chem 264: 18076–18082PubMedGoogle Scholar
  47. Zuber MX, John ME, Okamura T, Simpson ER, Waterman MR (1986) Bovine adrenocortical cytochrome P-45017α. Regulation of gene expression by ACTH and elucidation of primary sequence. J Biol Chem 261: 2475–2482PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • W. N. Kühn-Velten

There are no affiliations available

Personalised recommendations